1. Introduction {#sec1-molecules-21-00457}
===============

*Wedelia trilobata* is a notoriously invasive weed in a wide range of tropical and subtropical areas \[[@B1-molecules-21-00457]\]. In southern China, this creeping, matforming perennial herb has caused significant damage to farmlands, forests, and orchards \[[@B2-molecules-21-00457],[@B3-molecules-21-00457]\]. Studies have shown that *W. trilobata* has a strong allelopathic potential on neighboring native plants \[[@B4-molecules-21-00457],[@B5-molecules-21-00457]\]. The major chemical constituents of *W.* *trilobata* are *ent*-kaurane diterpenes, sesquiterpene lactones, and triterpenes with a variety of biological activities, such as antibacterial, antitumor, hepatoprotective, and central nervous system depressant properties \[[@B6-molecules-21-00457]\]. We previously reported ten eudesmanolides isolated from this plant as potential inducers of plant systemic acquired resistance \[[@B7-molecules-21-00457]\]. As continuation of that work, twenty-six *ent*-kaurane diterpenoids including seven new ones **1**--**7** were obtained from the whole plant *W. trilobata* ([Figure 1](#molecules-21-00457-f001){ref-type="fig"}). All diterpenoids were evaluated against a panel of bacteria and fungi, and compounds **2**, **4**, **7**, **10**, **12**, and **13** showed weak inhibitory activities against *Monilia albicans* with MICs of *ca.* 125 μg/mL. Herein, we report the isolation and structural elucidation of these compounds, as well as their antimicrobial properties.

2. Results and Discussion {#sec2-molecules-21-00457}
=========================

2.1. Structure Elucidation of Compounds {#sec2dot1-molecules-21-00457}
---------------------------------------

Compound **1** was obtained as a white amorphous powder, with a molecular formula determined as C~25~H~38~O~5~ on the basis of HREIMS which indicated a molecular ion peak at *m*/*z* 418.2722 M^+^ (calcd. for C~25~H~38~O~5~, 418,2719). The IR spectrum revealed absorption bands of hydroxyl (3431 cm^−1^) and carbonyl (1711 cm^−1^) groups. In the ^1^H-NMR spectrum ([Table 1](#molecules-21-00457-t001){ref-type="table"}), the downfield olefinic proton at δ~H~ 6.02 (1H, q, *J* = 7.0 Hz) and two methyl signals at δ~H~ 1.82 (3H, s) and 1.92 (3H, d, *J* = 7.0 Hz), indicated the presence of an angeloyloxy group in **1** \[[@B8-molecules-21-00457]\].

Apart from five carbon signals assigned to the angeloyloxy group (δ~C~ 167.9, 128.1, 138.6, 20.9, and 16.0), the ^13^C-NMR (DEPT) spectrum of **1** ([Table 1](#molecules-21-00457-t001){ref-type="table"}) also exhibited 20 carbons composed of three methyls, eight methylenes, four methines (one oxygenated), and five quaternary carbons, which were consistent with a skeleton of an *ent*-kauranoid \[[@B9-molecules-21-00457]\]. In particular, the NMR spectroscopic features of **1** are similar to those of **8** (16α-hydroxy-*ent*-kauran-19-oic acid), and only differed in the appearance of an angeloyloxy group at C-3 in **1**. It was also confirmed by the chemical shift value of C-3 (δ~C~ 78.9, CH), C-9 (δ~C~ 56.1, CH) and the HMBC correlations ([Figure 2](#molecules-21-00457-f002){ref-type="fig"}) from H-3 (δ~H~ 4.50, dd, *J* = 12.2, 4.7 Hz) to C-1′ (δ~C~ 167.9, C), C-1 (δ~C~ 38.9, CH~2~), and C-18 (δ~C~ 24.7, CH~3~) as well as the correlations from Me-20, H-12, and H-15 to C-9, and from the methyl at C-4 (Me-18) to a downfield quaternary carbon (C-19) at δ~C~ 178.1. The ROESY correlations of H-3 with H-5 and H~3~-18 suggested that the angeloyloxy was α-orientated, and the hydroxy at C-16 was also assigned as α-orientated by the ROESY correlations of H~3~-17 with H~2~-11 and H-14β along with the ROESY correlations of H~3~-20 with H~2~-15. Consequently, the structure of **1** was finally determined as 3α-angeloyloxy-16α-hydroxy-*ent*-kauran-19-oic acid.

Compound **2** had the molecular formula C~25~H~38~O~6~ as determined by the HREIMS, with 16 mass units more than **1**. The ^1^H- and ^13^C-NMR data similarities between **2** and **1** ([Table 1](#molecules-21-00457-t001){ref-type="table"} and [Table 2](#molecules-21-00457-t002){ref-type="table"}) suggested that they were structural analogues. As compared with compound **1**, the main differences were due to the presence of a hydroxymethyl group (δ~C~ 66.8) and the absence of a methyl group in **2**. The hydroxymethyl group was assigned to C-17 by the HMBC correlations of H~2~-17 to C-14, C-15, and C-16. Therefore, the structure of **2** was established as shown.

Compounds **3** and **4** showed the same mass units as those of **1** and **2**, respectively, on the basis of the HREIMS. The 1D NMR data of **3** and **4** ([Table 1](#molecules-21-00457-t001){ref-type="table"} and [Table 2](#molecules-21-00457-t002){ref-type="table"}) also closely resembled those of **1** and **2**, respectively, except for the presence of the tigloyloxy group at C-3 of **3** and **4** instead of the angeloyloxy group. These conclusions were verified by the HMBC correlations from H-3′ (δ~H~ 6.80 in **3**, δ~H~ 6.89 in **4**) and H-3 (δ~H~ 4.50 in **3**, δ~H~ 4.50 in **4**) to C-1′ (δ~C~ 167.9 in **3**, δ~C~ 169.4 in **4**). The NMR data suggested that compounds **3** and **4** possessed the same relative configuration as those of **1** and **2**, respectively. Thus, compounds **3** and **4** were determined as 3α-tigloyloxy-16α-hydroxy-*ent*-kauran-19-oic acid and 3α-tigloyloxy-16α, 17-dihydroxy-*ent*-kauran-19-oic acid, respectively.

Compound **5**, a white powder, possessed the molecular formula C~29~H~38~O~4~, as determined by the HREIMS, ^13^C-NMR ([Table 2](#molecules-21-00457-t002){ref-type="table"}) and DEPT data. Comparison of the 1D- and 2D-NMR spectroscopic data of **5** with those of 3*α*-cinnamoyloxy-*ent*-kaur-16-en-19-oic acid (**15**) revealed that their structures were closely similar to each other. The only difference between them was that the double bond of the cinnamoyloxy group at C-3 in **15** was reduced in **5**, which was supported by the molecular weights of **5**, showing two mass units more than those of **15**. This was further confirmed by the HMBC cross-peaks of H-2′ and H-3′ with C-1′ and C-4′. The α-orientation of the 3-dihydrocinnamoyloxy group was apparent from the ROESY correlations of H-3β with H-5β and H~3~-18β. Thus, compound **5** was determined as 3α-dihydrocinnamoyloxy-*ent*-kaur-16-en-19-oic acid.

The molecular formula of compound **6** was deduced as C~29~H~34~O~4~ on the basis of the positive HREIMS at *m*/*z* 446, 2463 \[M\]^+^ (calcd. for 446,2457). The ^1^H- and ^13^C-NMR data of **6** ([Table 1](#molecules-21-00457-t001){ref-type="table"} and [Table 2](#molecules-21-00457-t002){ref-type="table"}) showed many similarities to those of **20**, indicating that they were structural analogues as *ent*-kaura-9(11),16-dien-19-oic acid. As compared with compound **20**, the obvious difference was due to the presence of one more cinnamoyloxy group at C-3 in **6**. HMBC correlations from H-3, H-2′, and H-3′ to C-1′ further validated the conclusion above. The ROESY correlations of H-3 with H-5 and H~3~-18 suggested that the cinnamoyloxy was α-orientated. Consequently, the structure of **6** was determined as 3α-cinnamoyloxy-*ent*-kaura-9(11), 16-dien-19-oic acid.

Compound **7** was isolated as a white powder, and its molecular formula was determined as C~29~H~36~O~6~ by HREIMS based on *m*/*z* 480.2508 \[M\]^+^ (calcd. for 480,2512). The IR spectrum showed absorptions at 3441 (OH), 1701 (C = O), and 1639 and 1449 cm^−1^ (aromatic C = C). The presence of a cinnamoyloxy moiety was deduced by comparison with the NMR data ([Table 1](#molecules-21-00457-t001){ref-type="table"} and [Table 2](#molecules-21-00457-t002){ref-type="table"}) of compound **6**. Besides this cinnamoyloxy moiety, the remaining twenty C-atoms included a trisubstituted double bond (δ~H~ 5.58 (br. s); δ~C~ 134.2 and 149.2), a carboxyl group (δ~C~ 176.0), an O-bearing methylene group (δ~H~ 4.10 (d, *J* = 14.3 Hz) and 4.14 (d, *J* = 14.3 Hz); δ~C~ 60.9), and an O-bearing quaternary carbon (δ~C~ 75.6). Further analyses demonstrated that compound **7** showed a closely similar NMR pattern to that of **6**, indicating that compound **7** was a structural analogue of *ent*-kaurane-19-oic acid. The double bond was located between C-15 and C-16 by the HMBC cross-peaks of H-15 with C-8, C-14, C-16 and C-17. Meanwhile, the O-bearing methylene group was only connected to C-17 by the HMBC correlations from H~2~-17 to C-14, C-15, and C-16. At last, the O-bearing quaternary carbon could be attributed to C-9 due to the HMBC correlations of H~2~-7, H~2~-11, and H~3~-20 to C-9. The relative configuration of **7** was shown to be identical with that of 6 by NMR analysis. Thus, compound **7** was determined as 3α-cinnamoyloxy-9β, 17-dihydroxy-*ent*-kaur-15-en-19-oic acid.

Nineteen known *ent*-kaurane derivatives, namely 16α-hydroxy-*ent*-kauran-19-oic acid (**8**) \[[@B10-molecules-21-00457]\], 16α-methoxy-17-hydroxy-*ent*-kauran-19-oic acid (**9**) \[[@B11-molecules-21-00457]\], 16α-17-dihydroxy-*ent*-kauran-19-oic acid (**10**) \[[@B12-molecules-21-00457]\], 16α, 18-dihydroxy-*ent*-kaurane (**11**) \[[@B13-molecules-21-00457]\], 3α-tigloyloxypterokaurene L3 (**12**) \[[@B14-molecules-21-00457]\], 3α-angeloyloxy-9β-hydroxy-*ent*-kaur-16-en-19-oic acid (**13**) \[[@B15-molecules-21-00457]\], 3α-cinnamoyloxy-9β-hydroxy-*ent*-kaur-16-en-19-oic acid (**14**) \[[@B15-molecules-21-00457]\], 3α-cinnamoyloxy-*ent*-kaur-16-en-19-oic acid (**15**) \[[@B12-molecules-21-00457]\], 3α-hydroxy-*ent*-kaur-16-en-19-oic acid (**16**) \[[@B16-molecules-21-00457]\], 3α-tiglinoyloxy-*ent*-kaur-16-en-19-oic acid *ent*-kaura-9 (**17**) \[[@B8-molecules-21-00457]\], *ent*-9α-hydroxy-16-kauren-19-oic acid (**18**) \[[@B17-molecules-21-00457]\], *ent*-15-oxokaur-16-en-19-oic acid (**19**) \[[@B18-molecules-21-00457]\], (11),16-dien-19-oic acid (**20**) \[[@B19-molecules-21-00457]\], 12α-hydroxy-*ent*-kaur-9(11),16-dien-19-oic acid (**21**) \[[@B20-molecules-21-00457]\], 12α-methoxy-*ent*-kaur-9(11),16-dien-19-oic acid (**22**) \[[@B21-molecules-21-00457]\], 3α-hydroxy-*ent*-kaura-9(11), 16-dien-19-oic acid (**23**) \[[@B21-molecules-21-00457]\], *ent*-17-oxokaur-15-en-19-oic acid (**24**) \[[@B22-molecules-21-00457]\], 15α,16α-epoxy-17-hydroxy-*ent*-kauran-19-oic acid (**25**) \[[@B12-molecules-21-00457]\], and wedeliaseccokaurenolide (seco) (**26**) \[[@B14-molecules-21-00457]\], were also isolated. Their structures were identified on the basis of spectroscopic analysis and comparison with reported data.

The *in vitro* antimicrobial activities of all *ent*-kaurane derivatives isolated were tested against *Pseudomonas aeruginosa* (ATCC 27853), *Staphyloccocus aureus* (ATCC 25923), *Monilia albicans* (ATCC Y0109) and *Escherichia coli* (ATCC 25922) using an agar well diffusion method \[[@B23-molecules-21-00457]\]. Compounds **2**, **4**, **7**, **10**, **12**, and **13** showed weak activities against *M. albicans* (zone of inhibition \> 10 mm at 1 mg/mL). The minimum inhibitory concentrations (MICs) of compounds above against *M. albicans*, 1R (R: methicillin-resistant *M. albicans*), 2R, 3R, 4R, 5R, and 535R were determined by the 2-fold dilution method ([Table 3](#molecules-21-00457-t003){ref-type="table"}). Fluconazole was used as standard drug for comparison.

2.2. Evaluation of Anti-Micobial Activity {#sec2dot2-molecules-21-00457}
-----------------------------------------

In summary, seven new and nineteen known *ent*-kaurane diterpenoid metabolites were obtained from whole plant *W. trilobata*, and some compounds exhibited weak antimicrobial activities. Moreover, we previously reported ten eudesmanolides as potential inducers of plant systemic acquired resistance isolated from this species \[[@B7-molecules-21-00457]\]. Above all, a conclusion that can be drawn is that diterpenes and sesquiterpenes are the main metabolites of *W. trilobata* and they may be significant as chemical defenses allowing this notoriously invasive weed to adapt to varying surroundings rapidly and effectively ([Figure 3](#molecules-21-00457-f003){ref-type="fig"}).

3. Experimental Section {#sec3-molecules-21-00457}
=======================

3.1. General Procedures {#sec3dot1-molecules-21-00457}
-----------------------

1D- and 2D-NMR spectra were recorder on either an AM-400 or a DRX-500 or an Avance III-600 spectrometer (Bruker, Karlsruhe, Germany) with TMS as an internal standard. Unless otherwise specified, chemical shifts (δ) were expressed in ppm. MS were measured on a HPLC-Thermo Finnigan LCQ Advantage ion trap mass spectrometer (Waters, Milford, PA, USA). Optical rotation was determined on a SEPA-300 polarimeter (Horiba, Tokyo, Japan). UV spectroscopic data were measured on a 210A double-beam spectrophotometer (Shimadzu, Kyoto, Japan). IR spectra of samples in KBr discs were recorded on a Tensor-27 spectrometer with KBr pellets (Bruker, Rheinstetten, Germany). Column chromatography (CC) was carried out on silica gel G (100−200 mesh, 200−300 mesh, Qingdao Haiyang Chemical Co., Qingdao, China), silica gel H (10−40 μm, Qingdao Haiyang Chemical Co.), Sephadex LH-20 (40−70 μm, Amersham Pharmacia Biotech AB, Uppsala, Sweden), and Lichroprep RP-18 gel (20−45 μm, Merck, Darmstadt, Germany). Semi-preparative HPLC was performed on an Agilent 1200 series instrument equipped with a quaternary pump, a vacuum degasser, an auto-sampler, a thermos-tatted column compartment with a Zorbax SB-C18 (10 μm; Agilent Co. Ltd, St. Louis, MO, USA) column (i.d. 9.4 mm × 250 mm), and a diode array detector. Thin-layer chromatography (TLC) was conducted on precoated silica gel plates GF 254 (Qingdao Haiyang Chemical Co.). TLC spots were visualized by heating silica gel plates sprayed with 10% H~2~SO~4~ in EtOH.

3.2. Plant Material {#sec3dot2-molecules-21-00457}
-------------------

The whole plant of *Wedelia trilobata* (L.) Hitchc was collected in Simao, Yunnan Province, China, in August 2011. The specimen was identified by Yu Chen of Kunming Institute of Botany (KIB), Chinese Academy of Sciences (CAS). A voucher specimen (H20110805) has been deposited in the State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany.

3.3. Extraction and Isolation {#sec3dot3-molecules-21-00457}
-----------------------------

Dried powder of the whole plant of *W. trilobata* (9 kg) was extracted under reflux with MeOH (70 L, three times for 4, 4, and 3 h). The solvent was removed under reduced pressure to give a residue (1020.0 g, 11.3%), which was suspended with water and then extracted with petroleum ether, chloroform, EtOAc, and *n*-BuOH successively. The extracts were evaporated under vacuum to afford the corresponding extracts of petroleum ether (200.0 g), chloroform (90.0 g), EtOAc (90.0 g), and *n*-BuOH (380.0 g). The EtOAc (90.0 g) extract was separated with a silica gel G column (100−200 mesh, 10 cm × 120 cm, 450.0 g), eluted with petroleum ether/acetone (*v*/*v* = 9:1, 7:3, 6:4, 1:1, 0:1, each 10 L), to give five fractions (1−5). Fraction 3 (12.0 g) was extensively chromatographed over column of silica gel (3.6 × 100 cm, 36.0 g) and Sephadex LH-20 (CHCl~3~−MeOH, 1:1, 3.2 × 140 cm) to afford compounds **1** (1.2 mg), **2** (10.1 mg), **3** (0.4 mg), **4** (20.0 mg), **11** (2.3 mg), **12** (3.0 mg), **13** (4.5 mg), **14** (4.8 mg) and **15** (4.0 mg). Fraction 4 (7.0 g) was subjected to a column of reversed-phase silica gel (5 cm × 50 cm, 100 g) eluted with a MeOH/H~2~O (50/50 to 100/0) gradient to yield four sub-fractions (A−D). Sub-fraction B (200 mg) was purified by semi-preparative HPLC with 70% MeOH in H~2~O as the mobile phase to yield **5** (6.7 mg, t~R~ = 13.54 min), **6** (1.8 mg, t~R~ = 14.30 min), and **7** (13.0 mg, t~R~ = 15.75 min). Sub-fraction C (2.2 g) was applied to silica gel (5 cm × 80 cm, 30 g) eluted with DCM (dichloromethanemethylene chloride)/MeOH (100/1 to 10/1) to yield four sub-fractions (C1 to C4), respectively. Sub-fraction C2 (320.0 mg) was purified by semi-preparative HPLC with 72% MeOH in H~2~O as the mobile phase to yield **16** (26.8 mg, t~R~ = 18.23 min), **17** (17.2 mg, t~R~ = 20.40 min), and **18** (1.7 mg, t~R~ = 21.62 min), and in a similar procedure, sub-fraction C3 (200.0 mg) yielded **19** (2.3 mg, t~R~ = 16.52 min), **20** (7.0 mg, t~R~ = 17.24 min), **21** (8.0 mg, t~R~ = 19.93 min), and **25** (4.0 mg, t~R~ = 20.92 min). By using the same purification procedures, sub-fraction C4 yielded **22** (6.5 mg), **23** (5.0 mg), and **24** (14.0 mg). Sub-fraction D was subjected to a column of Sephadex LH-20 gel (3.2 cm × 140 cm) eluted with MeOH to obtain six major sub-fractions, each of which was then purified by semi-preparative HPLC with the mobile phase MeOH/H~2~O (65/35) to produce compounds **8** (10.0 mg, t~R~ = 12.44 min), **9** (9.0 mg, t~R~ = 14.93 min), **10** (5.0 mg, t~R~ = 15.45 min), and **26** (37.1 mg, t~R~ = 16.75 min).

3.4. Data for ***1**--**7*** {#sec3dot4-molecules-21-00457}
----------------------------

*3α-Angeloyloxy-16α-hydroxy-ent-kauran-19-oic acid* (**1**): white powder, ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{20}$: −57.0 (*c* 0.07, MeOH); UV (MeOH) λ~max~ (log ε) 211.8 (3.6) nm; IR (KBr) ν~max~ 3431, 2927, 2854, 1711, 1626, 1461, 1382, 1235, 1163, 1122, 1044 cm^−1^; positive-ion ESI-MS *m*/*z* 441 \[M + Na\]^+^, 859 \[2M + Na\]+, HR-EIMS *m*/*z* 418.2722 M^+^ (calcd. for C~25~H~38~O~5~, 418.2719); ^1^H-NMR (CDCl~3~, 600 MHz) and ^13^C-NMR (CDCl~3~, 150 MHz), see [Table 1](#molecules-21-00457-t001){ref-type="table"} and [Table 2](#molecules-21-00457-t002){ref-type="table"}.

*3α-Angeloyloxy-16α,17-dihydroxy-ent-kauran-19-oic acid* (**2**): white powder, ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{20}$: −50.37 (*c* 0.09, MeOH); UV (MeOH) *λ*~max~ (log ε) 216 (3.79) nm; IR (KBr) ν~max~ 3432, 2931, 2869, 2853, 1707, 1641, 1454, 1356, 1236, 1021, 988 cm^−1^; ESIMS *m*/*z* 457 \[M + Na\]^+^; HREIMS *m*/*z* 434.2672 \[M\]^+^ (calcd. for C~25~H~38~O~6~, 434.2668); ^1^H- and ^13^C-NMR data see [Table 1](#molecules-21-00457-t001){ref-type="table"} and [Table 2](#molecules-21-00457-t002){ref-type="table"}.

*3α-Tigloyloxy-16α-hydroxy-ent-kauran-19-oic acid* (**3**): white powder, ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{20}$: −42.8 (*c* 0.1, MeOH); UV (MeOH) λ~max~ (log ε) 210.2 (3.6) nm; IR (KBr) ν~max~ 3442, 2927, 2854, 1705, 1624, 1446, 1383, 1122, 1080, 1007 cm^−1^; positive-ion ESI-MS *m*/*z* 441 \[M + Na\]^+^, 859 \[2M + Na\]+, HR-EIMS *m*/*z* 418.2723 M^+^ (calcd. for C~25~H~38~O~5~, 418.2719); ^1^H-NMR (CDCl~3~, 600 MHz) and ^13^C-NMR (CDCl~3~, 150 MHz), see [Table 1](#molecules-21-00457-t001){ref-type="table"} and [Table 2](#molecules-21-00457-t002){ref-type="table"}.

*3α-Tigloyloxy-16α,17-dihydroxy-ent-kauran-19-oic acid* (**4**): white powder, ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{20}$: −41.00 (*c* 0.10, MeOH); UV (MeOH) λ~max~ (log ε) 216 (3.84) nm; IR (KBr) ν~max~ 3431, 2929, 2868, 2851, 1706, 1649, 1464, 1384, 1270, 1151, 1126, 1083, 1053 cm^−1^; ESIMS *m*/*z* 457 \[M + Na\]^+^; HREIMS *m*/*z* 434.2677 \[M\]^+^ (calcd. for C~25~H~38~O~6~, 434.2668); ^1^H- and ^13^C-NMR data see [Table 1](#molecules-21-00457-t001){ref-type="table"} and [Table 2](#molecules-21-00457-t002){ref-type="table"}.

*3α-Diydrocinnamoyloxy-ent-kaur-16-en-19-oic acid* (**5**): white powder, ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{20}$: −64.00 (*c* 0.14, MeOH); UV (MeOH) λ~max~ (log ε) 204 (3.96), 261 (2.57) nm; IR (KBr) ν~max~ 3441, 2927, 2855, 1732, 1703, 1631, 1453, 1181 cm^−1^; ESIMS *m*/*z* 473 \[M + Na\]^+^; HREIMS *m*/*z* 450.2781 \[M\]^+^ (calcd. for C~29~H~38~O~4~, 450.2770); ^1^H- and ^13^C-NMR data see [Table 1](#molecules-21-00457-t001){ref-type="table"} and [Table 2](#molecules-21-00457-t002){ref-type="table"}.

*3α-Cinnamoyloxy-ent-kaura-9(11),16-dien-19-oic acid* (**6**): white powder, ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{20}$: −6.32 (*c* 0.14, MeOH); UV (MeOH) λ~max~ (log ε) 203 (3.74), 277 (3.67) nm; IR (KBr) ν~max~ 3450, 2931, 2866, 1636, 1387, 1173 cm^−1^; ESIMS *m*/*z* 469 \[M + Na\]^+^; HREIMS *m*/*z* 446.2463 \[M\]^+^ (calcd. for C~29~H~34~O~4~, 446.2457); ^1^H- and ^13^C-NMR data see [Table 1](#molecules-21-00457-t001){ref-type="table"} and [Table 2](#molecules-21-00457-t002){ref-type="table"}.

*3α-Cinnamoyloxy-9β,17-dihydroxy-ent-kaur-15-en-19-oic acid* (**7**): white powder, ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{20}$: −55.76 (*c* 0.11, MeOH); UV (MeOH) λ~max~ (log ε) 205 (4.21), 215 (4.20), 277 (4.28) nm; IR (KBr) ν~max~ 3441, 2925, 2863, 1701, 1639, 1449, 1311, 1281, 1204, 1185 cm^−1^; ES^−^--MS *m*/*z* 479 \[M − H\]^−^; HREIMS *m*/*z* 480.2508 \[M\]^+^ (calcd. for C~29~H~36~O~6~, 480.2512); ^1^H- and ^13^C-NMR data see [Table 1](#molecules-21-00457-t001){ref-type="table"} and [Table 2](#molecules-21-00457-t002){ref-type="table"}.

3.5. Antimicrobial Assays {#sec3dot5-molecules-21-00457}
-------------------------

The strains used in antimicrobial tests were obtained from the Research Center of Natural Medicine, Clinical School of Kunming General Hospital of Chengdu Military Command. The test organisms in this bioassay were the bacteria *Pseudomonas aeruginosa* (ATCC 27853), *Staphyloccocus aureus* (ATCC 25923) and *Escherichia coli* (ATCC 25922) (all grown on MH medium) and the fungus *Monilia albicans* (ATCC Y0109) (grown on Sabauraud′s medium). For the agar plate punch assay \[[@B23-molecules-21-00457]\], all tested compounds were dissolved in DMSO at a concentration of 1 mg/mL. Then, 50 μL of the solution was added onto a well (6 mm in diameter) that had been punched in the appropriate agar growth medium smeared with a suspension of the test organism (1.0 × 10^9^ cfu/mL; cfu = colony forming unit). All active compounds with a diameter of inhibition greater than 10 mm were submitted to minimum inhibitory concentration testing. The MICs of compounds **2**, **4**, **7**, **10**, **12**, and **13** against *M. albicans*, 1R (R: methicillin-resistant *M. albicans*), 2R, 3R, 4R, 5R, and 535R were determined using a 2-fold dilution method \[[@B23-molecules-21-00457]\]. The 2-fold serially diluted compounds in MH broth were dispensed into 96-well microtiter plates (100 μL/well), and then an aliquot of 5 × 10^4^ cfu/mL of bacterial culture was added to each well (100 μL/well) to final concentrations in a range of 1.95−250 μg/mL. After incubating at 37 °C for 18 h, the lowest concentration without any colony growth was recorded as the MIC value. The resulting values were compared with the value for a positive control (fluconazole, range 125--250 μg/mL) under the same conditions.

4. Conclusions {#sec4-molecules-21-00457}
==============

A systematic chemical search was performed and resulted in the separation of seven new *ent*-kaurane diterpenoids together with nineteen known *ent*-kaurane derivatives from *Wedelia trilobata* (L.) Hitchc, a notoriously invasive weed in South China. The structures of the new compounds were identified based on detailed spectroscopic analysis and comparison with the published data of analogues. All *ent*-kaurane derivatives isolated were tested against *Pseudomonas aeruginosa*, *Staphyloccocus* *aureus*, *Monilia albicans* and *Escherichia coli*, and compounds **2**, **4**, **7**, **10**, **12**, and **13** showed weak activities against *M. albicans*. Taken together with data from prior research \[[@B7-molecules-21-00457]\], the conclusion that diterpenes and sesquiterpenes are main metabolites of *W. trilobata* can be drawn and they may be significant as chemical defenses allowing this notoriously invasive weed to adapt to varying surroundings rapidly and effectively.
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###### 

^1^H-NMR Data for Compounds **1**--**7**.

  NO.       1 ^a^                      2 ^b^                      3 ^a^                      4 ^b^                      5 ^a^                      6 ^c^                      7 ^d^
  --------- -------------------------- -------------------------- -------------------------- -------------------------- -------------------------- -------------------------- --------------------------
  1a        0.97 (1H, \*)              1.05 (1H, s)               0.97 (1H, \*)              1.04 (1H, m)               1.03 (1H, d, 9.6)          1.55 (1H, m)               1.56 (1H, m)
  1b        1.88 (1H, br d, 13.5)      1.96 (1H, m)               1.87 (1H, br d, 13.7)      1.95 (1H, m)               1.94 (1H, br d)            2.01 (1H, \*)              2.18 (1H, td, 13.7, 4.3)
  2a        1.72 (1H, m)               1.70 (1H, m)               1.69 (1H, m)               1.65 (1H, m)               1.68 (1H, m)               1.87 (1H, m)               1.71 (1H, m)
  2b        2.30 (1H, m)               2.46 (1H, m)               2.27 (1H, m)               2.42 (1H, m)               2.33 (1H, m)               2.55 (1H, m)               2.57 (1H, m)
  3         4.50 (1H, dd, 12.2, 4.7)   4.56 (1H, dd, 12.1, 4.6)   4.50 (1H, dd, 12.2, 4.7)   4.50 (1H, dd, 12.1, 4.6)   4.52 (1H, dd, 12.2, 4.6)   4.77 (1H, dd, 12.0, 4.8)   4.61 (1H, dd, 12.5, 4.5)
  5         1.04 (1H, br d, 11.9)      1.12 (1H, d, 6.4)          1.04 (1H, br d, 11.9)      1.11 (1H, m)               1.08 (1H, m)               1.85 (1H, m)               1.93 (1H, dd, 12.5, 2.2)
  6a        1.61 (1H, \*)              1.67 (1H, m)               1.61 (1H, \*)              1.68 (1H, m)               1.63 (1H, m)               2.01 (1H, \*)              1.66 (1H, m)
  6b        1.80 (1H, \*)              1.87 (1H, m)               1.79 (1H, \*)              1.86 (1H, m)               1.84 (1H, m)               2.01 (1H, \*)              1.85 (1H, dd, 13.9, 2.4)
  7a        1.37 (1H, \*)              1.49 (1H, m)               1.37 (1H, \*)              1.47 (1H, dd, 10.3, 3.3)   1.45 (1H, m)               1.56 (1H, m)               1.29 (1H, t, 3.2)
  7b        1.59 (1H, \*)              1.65 (1H, m)               1.59 (1H, \*)              1.64 (1H, m)               1.53 (1H, \*)              2.10 (1H, m)               2.11 (1H, m)
  9         0.90 (1H, br s)            1.04 (1H, br d)            0.91 (1H, br s)            1.03 (1H, br s)            1.04 (1H, br s)                                       
  11a       1.49 (1H, \*)              1.63 (2H, \*)              1.49 (1H, \*)              1.62 (2H, m)               1.53 (1H, \*)              5.28 (1H, s)               1.47 (1H, m)
  11b       1.49 (1H, \*)                                         1.49 (1H, \*)                                         1.65 (1H, d, 4.9)                                     1.62 (1H, m)
  12a       1.44 (1H, m)               1.51 (1H, m)               1.43 (1H, m)               1.51 (1H, d, 3.8)          1.47 (1H, m)               2.03 (1H, m)               1.42 (1H, dd, 12.9, 5.3)
  12b       1.51 (1H, \*)              1.63 (1H, \*)              1.50 (1H, \*)              1.62 (1H, m)               1.56 (1H, m)               2.44 (1H, m)               2.01 (1H, m)
  13        1.77 (1H, \*)              2.03 (1H, br s)            1.77 (1H, \*)              2.02 (1H, br s)            2.62 (1H, s)               2.80 (1H, s)               2.53 (1H, m)
  14a       1.55 (1H, m)               1.63 (1H, \*)              1.55 (1H, m)               1.63 (1H, m)               1.12 (1H, m)               1.52 (1H, m)               1.48 (1H, dd, 5.0, 2.0)
  14b       1.81 (1H, \*)              1.89 (1H, m)               1.80 (1H, \*)              1.89 (1H, d, 11.3)         1.91 (1H, d, 11.0)         1.65 (1H, m)               2.24 (1H, d, 10.5)
  15a       1.50 (1H, \*)              1.41 (1H, d, 14.4)         1.50 (1H, \*)              1.40 (1H, d, 14.2)         2.05 (1H, br s)            2.24 (1H, d, 15.6)         5.58 (1H, br s)
  15b       1.50 (1H, \*)              1.53 (1H, d, 14.4)         1.50 (1H, \*)              1.54 (1H, d, 14.2)         2.05 (1H, br s)            2.64 (1H, d, 15.6)         
  17a       1.30 (3H, s)               3.60 (1H, d, 11.4)         1.30 (3H, s)               3.60 (1H, d, 11.3)         4.74 (1H, s)               4.84 (1H, s)               4.10 (1H, d, 14.3)
  17b       3.70 (1H, d, 11.4)         3.70 (1H, d, 11.3)         4.80 (1H, s)               4.95 (1H, s)               4.14 (1H, d, 14.3)                                    
  18        1.22 (3H, s)               1.23 (3H, s)               1.20 (3H, s)               1.20 (3H, s)               1.15 (3H, s)               1.35 (3H, s)               1.26 (3H, s)
  20        0.97 (3H, s)               1.07 (3H, s)               0.97 (3H, s)               1.07 (3H, s)               1.01 (3H, s)               1.19 (3H, s)               1.18 (3H, s)
  3-ester   6.02 (1H, q, 7.0)          6.11 (1H, dq, 7.0, 1.4)    6.80 (1H, q, 7.1)          6.89 (1H, dq, 7.0, 1.2)    2.68 (2H, dd, 15.0, 7.2)   6.46 (1H, d, 16.2)         6.53 (1H, d, 15.8)
            1.92 (3H, d, 7.0)          1.96 (3H, dd, 7.2, 1.5)    1.72 (3H, d, 7.1)          1.79 (3H, d, 7.2)          2.95 (2H, m)               7.70 (1H, d, 16.2)         7.68 (1H, d, 15.8)
            1.82 (3H, s)               1.86 (3H, s)               1.76 (3H, s)               1.81 (3H, s)               7.26 (2H, m)               7.53 (2H, m)               7.67 (2H, m)
                                                                                                                        7.19 (2H, \*)              7.40 (2H, \*)              7.43 (2H, \*)
                                                                                                                        7.19 (1H, \*)              7.40 (1H, \*)              7.43 (1H, \*)

^a^ Recorded in CDCl~3~ at 400 MHz; ^b^ Recorded in CD~3~OD at 400 MHz; ^c^ Recorded in CDCl~3~ at 600 MHz; ^d^ Recorded in acetone-*d*~6~ at 400 MHz. \* Overlapped.
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###### 

^13^C-NMR Data for Compounds **1**--**7**.

  No.       1 ^a^     2 ^b^     3 ^a^     4 ^b^     5 ^a^     6 ^c^     7 ^d^
  --------- --------- --------- --------- --------- --------- --------- ---------
  1         38.9 t    40.0 t    38.9 t    40.0 t    38.7 t    39.5 t    30.7 t
  2         24.3 t    25.3 t    24.2 t    25.1 t    25.3 t    25.0 t    24.7 t
  3         78.9 d    80.7 t    79.0 d    80.8 t    79.0 d    79.5 d    79.9 d
  4         48.0 s    48.8 s    48.1 s    49.0 s    47.8 s    49.6 s    48.3 s
  5         56.4 d    57.3 d    56.4 d    57.3 d    56.3 d    46.0 d    49.6 d
  6         21.9 t    23.0 t    22.0 t    23.0 t    21.4 t    18.9 t    21.5 t
  7         41.9 t    43.0 t    41.9 t    43.0 t    40.9 t    38.1 t    34.8 t
  8         45.2 s    45.5 s    45.2 s    45.5 s    43.8 s    42.3 s    54.2 s
  9         56.1 d    57.3 d    56.0 d    57.3 d    55.1 d    155.6 s   75.6 s
  10        39.5 s    40.5 s    39.5 s    40.5 s    39.3 s    38.4 s    44.4 s
  11        18.5 t    19.7 t    18.5 t    19.7 t    18.5 t    115.2 t   26.6 t
  12        26.9 t    27.2 t    26.9 t    27.2 t    33.0 t    38.0 t    31.5 t
  13        49.0 d    46.2 d    48.9 d    46.2 d    43.7 d    41.2 d    41.1 d
  14        37.6 t    38.0 t    37.5 t    38.0 t    39.4 t    44.9 t    45.1 t
  15        57.5 t    53.5 t    57.5 t    53.5 t    48.7 t    51.0 d    134.2 d
  16        79.6 s    82.8 s    79.7 s    82.8 s    155.0 s   158.2 s   149.2 s
  17        24.1 q    66.8 t    24.1 q    66.8 t    103.0 t   106.0 t   60.9 t
  18        24.7 q    24.5 q    24.7 q    24.5 q    23.6 q    24.3 q    24.4 q
  19        178.1 s   177.9 s   178.3 s   178.1 s   180.0 s   178.1 s   176.0 s
  20        15.7 q    16.1 q    15.7 q    16.1 q    15.3 q    23.3 q    17.4 q
  3-ester   167.9 s   169.4 s   167.9 s   169.4 s   173.0 s   166.8 s   166.9 s
            128.1 s   129.3 s   128.9 s   129.5 s   36.0 t    118.4 d   119.5 d
            138.6 d   139.0 d   137.8 d   138.8 d   30.9 t    145.3 d   145.2 d
            16.0 q    16.0 q    14.7 q    14.4 q    140.0 s   134.5 s   135.4 s
            20.9 q    20.9 q    12.3 q    12.1 q    128.0 d   128.4 d   129.0 d
                                                    128.0 d   129.1 d   131.1 d
                                                    126.0 d   130.5 d   129.8 d

^a^ Recorded in CDCl~3~ at 100 MHz; ^b^ Recorded in CD~3~OD at 100 MHz; ^c^ Recorded in CDCl~3~ at 150 MHz; ^d^ Recorded in acetone-*d*~6~ at 100 MHz.
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###### 

Antimicrobial activities of compounds **2**, **4**, **7**, **10**, **12** and **13**.

  Compounds         Antimicrobial Activities (MIC in μg/mL)                                           
  ----------------- ----------------------------------------- ------- ------- ------- ------- ------- -------
  **2**             125                                       \>250   \>250   \>250   \>250   \>250   \>250
  **4**             125                                       125     \>250   \>250   \>250   \>250   \>250
  **7**             125                                       \>250   \>250   \>250   \>250   \>250   \>250
  **10**            125                                       \>250   \>250   \>250   \>250   \>250   \>250
  **12**            125                                       \>250   \>250   \>250   \>250   \>250   \>250
  **13**            125                                       \>250   \>250   \>250   \>250   \>250   \>250
  Fluconazole ^a^   125                                       \>250   \>250   \>250   \>250   \>250   \>250

^a^ Positive control; ^b^ R means methicillin-resistant *M. albicans*.

[^1]: These authors contributed equally to this work.
